Monitoring Crohn's disease with Magnetic resonance index of activity (MaRIA) and Clermont score: correlation with SES-CD and fecal calprotectin

Congress:

ECR 2020

Poster Number:

C-14790

Type:

Scientific Exhibit

Keywords:

MR-Enterography, Small bowel, Gastrointestinal tract, Abdomen, GI Tract, Outcomes analysis, Image verification, Inflammation, Prospective, Diagnostic or prognostic study, Performed at one institution

Authors:

F. A. Carpagnano, A. Lacanna, M. R. Petrera, A. N. Cintoli, L. P. Stoppino, R. Vinci, L. Macarini; foggia/IT

DOI:

10.26044/ecr2020/C-14790

DOI-Link:

https://dx.doi.org/10.26044/ecr2020/C-14790

References

1. Ordas I, Rimola J, Rodriguez S et al. Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients with Crohn’s Disease. Gastroenterology. 2014; 146: 374–382.
2. Van Assche G, Herrmann KA, Louis E, et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn’s disease. J Crohns Colitis 2013; 7:950–957.
3. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 2009; 58:1113–1120.
4. Rimola J, Ordas I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17:1759–1768.
5. Buisson A, JoubertA, Montoriol P-F et al. Diffusion-weighted magneticresonance imaging for detecting and assessing ileal inflammation inCrohn’sdisease . Aliment PharmacolTher2013;37: 537 – 545.
6. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 2010; 362:1383–1395.
7. Ferrante M, Noman M, Vermeire S, et al. Evolution of endoscopic activity scores under placebo therapy in Crohn’s disease. Gastroenterology 2010; 138:S358.
8. Moskovitz DN, Daperno M, Van Assche G, et al. Defining and validating cut-offs for the simple endoscopic score for Crohn’s disease. Gastroenterology 2007;132:S1097.
9. Hordonneau C, Buisson A, Scanzi J, Goutorbe F, Pereira B, Borderon C, Da Ines D, Montoriol PF, Garcier JM, Boyer L, Bommelaer G, Petitcolin V. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol 2014; 109:89-98.
10. Oto A, Zhu F, Kulkarni K, Karczmar GS, Turner JR, Rubin D. Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn’s disease. AcadRadiol 2009; 16:597–603.
11. Oto A, Kayhan A, Williams JT, Fan X, Yun L, Arkani S, Rubin DT. Active Crohn’s disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J MagnReson Imaging 2011; 33:615-24.